Fingerprint
Dive into the research topics of 'Phase II trial of bevacizumab with dose-dense paclitaxel as first-line treatment in patients with advanced ovarian cancer'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Phase II trial of bevacizumab with dose-dense paclitaxel as first-line treatment in patients with advanced ovarian cancer
Nicole D. Fleming, Robert L. Coleman, Celestine Tung, Shannon N. Westin, Wei Hu, Yunjie Sun, Priya Bhosale, Mark F. Munsell, Anil K. Sood
Research output: Contribution to journal › Article › peer-review
15
Scopus
citations